Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing-The iBolus-In subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: A randomized controlled trial

Diabetes Technology and Therapeutics

Volumn 14, Issue 11, 2012, Pages 1043-1052

  Rossetti, Paolo ^a   Ampudia Blasco, F Javier ^b   Laguna, Alejandro ^a   Revert, Ana ^a   Vehì, Josep ^c   Ascaso, Juan F ^b   Bondia, Jorge ^a  

^a UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c UNIVERSITY OF GIRONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GLUCOSE; INSULIN;

ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTINUOUS GLUCOSE MONITORING; CONTINUOUS INFUSION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IBOLUS; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MALE; MEAL; MULTIPLE REGRESSION; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TBOLUS; VALIDATION PROCESS;

ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DOUBLE-BLIND METHOD; FEMALE; GLYCEMIC INDEX; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MONITORING, AMBULATORY; POSTPRANDIAL PERIOD; PROSPECTIVE STUDIES; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 84868024240     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0145     Document Type: Article

References (25)

1. American Diabetes Association: Standards of medical care in diabetes - 2012. Diabetes Care 2012;35(Suppl 1):S11-S63.
2. Monnier L, Colette C, Owens DR: Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol 2008;2:1094-1100.
3. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group: Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010;363:311-320. Erratum in N Engl J Med 2010;363:1092.
4. Agrawal P, Welsh JB, Kannard B, Askari S, Yang Q, Kaufman FR: Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump. J Diabetes Sci Technol 2011;5:1137-1141.
5. Davidson PC, Hebblewhite HR, Steed RD, Bode BW: Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocr Pract 2008;14:1095-101.
6. Walsh J, Roberts R, Bailey T: Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels. J Diabetes Sci Technol 2010;4:1174-1181.
7. Zisser H, Robinson L, Bevier W, Dassau E, Ellingsen C, Doyle FJ III, Jovanovic L: Bolus calculator: a review of four ''smart'' insulin pumps. Diabetes Technol Ther 2008;10:441- 444.
8. Revert A, Calm R, Vehi J, Bondia J: Calculation of the best basal-bolus combination for postprandial glucose control in insulin pump therapy. IEEE Trans Biomed Eng 2011;58:274- 281.
9. Revert A, Rossetti P, Calm R, Vehí J, Bondia J: Combining basal-bolus insulin infusion for tight postprandial glucose control: an in silico evaluation in adults, children, and adolescents. J Diabetes Sci Technol 2010;4:1424-1437.
10. Jaulin L, Kieffer M, Didrit O, Walter E: Applied Interval Analysis. London: Springer, 2001.
11. Ewing DJ, Martyn CN, Young RJ, Clarke BF: The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985;8:491-498. (Pubitemid 15240914)
12. Laguna AJ, Rossetti P, Ampudia-Blasco FJ, Vehí J, Bondia J: Optimal design for individual model identification based on ambulatory continuous glucose monitoring in patients with type 1 diabetes. In: Proceedings of the United Kingdom Automatic Control Council International Conference on Control, June 2010. http://ukacc.group.shef.ac.uk/?page-id = 87 (accessed August 2012).
13. Walsh JT, Roberts R: Pumping Insulin. San Diego, CA: Torrey Pines Press, 2006:332.
14. McGuire EA, Helderman JH, Tobin JD, Andres R, Berman M: Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 1976;41:565-573.
15. Winer BJ, Brown DR, Michels KM: Statistical Principles in Experimental Design. New York: McGraw-Hill, 1991:1057.
16. Wilinska ME, Chassin LJ, Schaller HC, Schaupp L, Pieber TR, Hovorka R: Insulin kinetics in type-I diabetes: continuous and bolus delivery of rapid acting insulin. IEEE Trans Biomed Eng 2005;52:3-12. (Pubitemid 40065604)
17. Panunzi S, Palumbo P, De Gaetano A: A discrete single delay model for the intra-venous glucose tolerance test. Theor Biol Med Model 2007;4:35.
18. Dalla Man C, Camilleri M, Cobelli C: A system model of oral glucose absorption: validation on gold standard data. IEEE Trans Biomed Eng 2006;53:2472-2478. (Pubitemid 46019534)
19. Basu R, Di Camillo B, Toffolo G, Basu A, Shah P, Vella A, Rizza R, Cobelli C: Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol Endocrinol Metab 2003;284:E55-E69. (Pubitemid 36076223)
20. Hermansen K, Rasmussen O, Arnfred J, Winther E, Schmitz O: Glycemic effects of spaghetti and potato consumed as part of mixed meal on IDDM patients. Diabetes Care 1987;10:401-406. (Pubitemid 17133600)
21. MacDonald K, Lowe JM, Barker D, Mensch M, Attia J: Effect of popular takeaway foods on blood glucose levels in type 1 diabetes mellitus patients on intensive insulin therapy. Int JClin Pract 2009;63:189-194.
22. O'Connell MA, Gilbertson HR, Donath SM, Cameron FJ: Optimizing postprandial glycemia in pediatric patients with type 1 diabetes using insulin pump therapy: impact ofglycemic index and prandial bolus type. Diabetes Care 2008;31:1491-1495.
23. Garci'a-Jaramillo M, Calm R, Bondia J, Tari'n C, Vehi J: Insulin dosage optimization based on prediction of postprandial glucose excursions under uncertain parameters and food intake. Comput Methods Programs Biomed 2012; 105:61-69.
24. Heinemann L: Variability of insulin absorption and insulin action. Diabetes Technol Ther 2002;4:673-682. (Pubitemid 35283332)
25. Pan'kowska E, B1azik M, Groele L. Does the fat-protein meal increase postprandial glucose level in type 1 diabetes patients on insulin pump: the conclusion of a randomized study. Diabetes Technol Ther 2012;14:16-22.